Latest News

Higher ARR Linked to AF and Stroke Risk in Older Adults
Written by: Radcliffe CKM
Higher ARR Linked to AF and Stroke Risk in Older Adults
Oral Orforglipron Superior to Semaglutide for T2D Control
Written by: Radcliffe CKM
Oral Orforglipron Superior to Semaglutide for T2D Control
Empagliflozin and Finerenone: Hyperkalemia Risk in CKD
Written by: Radcliffe CKM
Empagliflozin and Finerenone: Hyperkalemia Risk in CKD
Pelacarsen Cuts Lipoprotein Apheresis Need in CVD
Written by: Radcliffe CKM
Pelacarsen Cuts Lipoprotein Apheresis Need in CVD
Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia
Written by: Radcliffe CKM
Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia
Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2
Written by: Radcliffe CKM
Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2
Enlicitide: Oral PCSK9 Inhibitor Lowers LDL-C by 56%
Written by: Radcliffe Cardiology
Enlicitide: Oral PCSK9 Inhibitor Lowers LDL-C by 56%
Study: 6 in 10 US Adults Eligible for CKM Drugs
Written by: Radcliffe CKM
Study: 6 in 10 US Adults Eligible for CKM Drugs
BI 764198 Reduces Proteinuria in FSGS Phase 2 Trial
Written by: Radcliffe CKM
BI 764198 Reduces Proteinuria in FSGS Phase 2 Trial
Metabolite Profile Predicts Future Type 2 Diabetes Risk
Written by: Radcliffe CKM
Metabolite Profile Predicts Future Type 2 Diabetes Risk

External news

Written by: Medscape
Rapid US Aging Ups Need for Minimally Invasive Care and AI
Written by: Medscape
Carotid Wall Thickness Signals Changes in the Heart
Written by: Cardiac Vascular News
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
Written by: Cardiac Vascular News
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction
Written by: Medscape
Heart Failure
Written by: Cardiac Vascular News
Embolx Secures New CMS HCPCS Level II G-Code for Pressure-Generating Catheter Procedures Performed in the Physician Office (OBL)
Written by: Cardiac Vascular News
FDA APPROVES LABELING UPDATE REFLECTING EVIDENCE IN RUPTURED AAA FOR GORE® EXCLUDER® AAA ENDOPROSTHESIS AND GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS
Written by: Cardiovascular Business
Cardiologist’s lawsuit against former employer dismissed
Written by: Medscape
Study Probes Absolute Risk for ION With GLP-1 Agents
Written by: Cardiovascular Business
New SCCT president, a veteran cardiologist, highlights importance of listening and teamwork